Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1971 1
1972 3
1974 4
1975 2
1976 6
1977 9
1978 11
1979 10
1980 11
1981 11
1982 9
1983 3
1984 7
1985 8
1986 7
1987 17
1988 14
1989 13
1990 6
1991 6
1992 5
1993 4
1994 5
1995 3
1996 4
1997 6
1998 1
2000 7
2001 2
2003 1
2004 1
2005 2
2006 1
2007 2
2009 2
2010 1
2011 3
2012 3
2013 2
2014 3
2015 3
2016 7
2017 2
2018 5
2019 2
2020 3
2021 7
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Among authors: riccardi v. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.
Legius E, Messiaen L, Wolkenstein P, Pancza P, Avery RA, Berman Y, Blakeley J, Babovic-Vuksanovic D, Cunha KS, Ferner R, Fisher MJ, Friedman JM, Gutmann DH, Kehrer-Sawatzki H, Korf BR, Mautner VF, Peltonen S, Rauen KA, Riccardi V, Schorry E, Stemmer-Rachamimov A, Stevenson DA, Tadini G, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Evans DG, Plotkin SR. Legius E, et al. Among authors: riccardi v. Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19. Genet Med. 2021. PMID: 34012067 Free PMC article.
Neurofibromatosis update.
Riccardi VM. Riccardi VM. Neurofibromatosis. 1989;2(5-6):284-91. Neurofibromatosis. 1989. PMID: 2518510 Review.
Neurofibromatosis.
Spira M, Riccardi V. Spira M, et al. Among authors: riccardi v. Clin Plast Surg. 1987 Apr;14(2):315-25. Clin Plast Surg. 1987. PMID: 3107867
Duality of Nrf2 in iron-overload cardiomyopathy.
Federti E, Vinchi F, Iatcenko I, Ghigo A, Matte A, Toya SCM, Siciliano A, Chiabrando D, Tolosano E, Vance SZ, Riccardi V, Andolfo I, Iezzi M, Lamolinara A, Iolascon A, De Franceschi L. Federti E, et al. Among authors: riccardi v. Haematologica. 2023 May 1;108(5):1335-1348. doi: 10.3324/haematol.2022.281995. Haematologica. 2023. PMID: 36700398 Free PMC article.
Von Recklinghausen neurofibromatosis.
Riccardi VM. Riccardi VM. N Engl J Med. 1981 Dec 31;305(27):1617-27. doi: 10.1056/NEJM198112313052704. N Engl J Med. 1981. PMID: 6796886 Review. No abstract available.
Neurofibromatosis heterogeneity.
Riccardi VM. Riccardi VM. J Am Acad Dermatol. 1984 Mar;10(3):518-9. doi: 10.1016/s0190-9622(84)80104-8. J Am Acad Dermatol. 1984. PMID: 6427302 No abstract available.
The neurofibromatosis: which one and why?
Riccardi VM. Riccardi VM. Arq Neuropsiquiatr. 2014 Mar;72(3):177-8. doi: 10.1590/0004-282x20140012. Arq Neuropsiquiatr. 2014. PMID: 24676432 Free article. No abstract available.
Neurofibromatosis: clinical heterogeneity.
Riccardi VM. Riccardi VM. Curr Probl Cancer. 1982 Aug;7(2):1-34. doi: 10.1016/s0147-0272(82)80016-0. Curr Probl Cancer. 1982. PMID: 6816509 Review. No abstract available.
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury.
Federti E, Matte A, Recchiuti A, Garello F, Ghigo A, El Nemer W, Terreno E, Amoresano A, Mattoscio D, Turrini F, Lebouef C, Janin A, Pantaleo A, Russo R, Marin M, Iatcencko I, Riccardi V, Siciliano A, Iolascon A, Brugnara C, De Franceschi L. Federti E, et al. Among authors: riccardi v. Hemasphere. 2023 Feb 28;7(3):e848. doi: 10.1097/HS9.0000000000000848. eCollection 2023 Mar. Hemasphere. 2023. PMID: 36874380 Free PMC article.
250 results